The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 27, 2024

Filed:

Nov. 02, 2018
Applicant:

Nouscom Ag, Basel, CH;

Inventors:

Alfredo Nicosia, Basel, CH;

Elisa Scarselli, Basel, CH;

Armin Lahm, Basel, CH;

Antonella Folgori, Basel, CH;

Assignee:

NOUSCOM AG, Basel, CH;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 14/46 (2006.01); A61P 35/00 (2006.01); A61K 39/00 (2006.01); A61K 39/39 (2006.01); C12N 15/86 (2006.01); A61K 38/00 (2006.01); A61K 39/385 (2006.01); C12N 7/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/461 (2013.01); A61K 39/0011 (2013.01); A61K 39/385 (2013.01); A61K 39/39 (2013.01); A61P 35/00 (2018.01); C12N 7/00 (2013.01); C12N 15/86 (2013.01); A61K 38/00 (2013.01); A61K 2039/53 (2013.01); A61K 2039/6031 (2013.01); A61K 2039/70 (2013.01); C07K 2319/03 (2013.01); C07K 2319/40 (2013.01); C12N 2710/10343 (2013.01); C12N 2710/10371 (2013.01);
Abstract

Polypeptides comprising a fragment of a teleost invariant chain fused to one or more antigens can enhance T cell response. Alternatively a teleost invariant chain fused to one or more antigens or antigenic fragments thereof can be used. A polynucleotide encoding such polypeptides, vectors comprising such polynucleotides, collection of vectors comprising such polynucleotides are also disclosed. The use of such polypeptides, polynucleotides, vectors for treating or preventing diseases, in particular tumor diseases are also encompassed by the present invention. The teleost invariant chain polypeptides or fragments thereof act as 'T cell enhancer' converting non-immunogenic antigenic sequences into immunogenic T cell antigens.


Find Patent Forward Citations

Loading…